Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05784103 · ClinicalTrials.gov registry record · NA
Comparison of Tissue Oxygenation Measurement Using Multimodal Devices
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05784103 is a NA study that has completed, run by Indiana University. The registered enrollment target is 20 participants.
The verdict
NCT05784103, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Pulse oximeters are common medical devices used to measure blood oxygen saturation (SpO2). These devices are either stand-alone or integrated into physiologic monitoring systems, using 2 wavelengths of light to determine SpO2. With recent advances in technology, Spatial Frequency Domain Imaging (SFDI) uses a range of light wavelengths from red to near-infrared (NIR), and smartphones such as Apple Watch, and transcutaneous oximetry TCOM now have pulse oximetry capabilities. Since it is possible that most patients could utilize this technology, we sought to assess the accuracy, reliability, and usability of these oximeters and compare outcomes. In this study, a cohort of 20 healthy volunteers above the age of 18 including males and females of different skin colors will be assessed at the same site and data will be compared. We aim to provide a set of data that will support the clinical and scientific community and identify more than one reliable skin oxygen measurement modality.
Interventions
- DEVICE Clarifi Modulum
- DEVICE Perimed PeriFlux 5000
- DEVICE Apple Watch Oxygen Sensor
- DEVICE Innovo iP 900AP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-03-09 |
| Est. Completion | 2022-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05784103
The ClinicalTrials.gov registry entry for NCT05784103 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Clarifi Modulum is the first listed.
NCT05784103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05784103 about?
NCT05784103 is a clinical study titled "Comparison of Tissue Oxygenation Measurement Using Multimodal Devices". Pulse oximeters are common medical devices used to measure blood oxygen saturation (SpO2). These devices are either stand-alone or integrated into physiologic monitoring systems, using 2 wavelengths of light to determine SpO2. With recent advances in technology, Spatial Frequency Domain Imaging (SFD...
What is the current status of trial NCT05784103?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-03-09. Estimated completion is 2022-07-07.
What interventions are being tested in trial NCT05784103?
The interventions under investigation include: Clarifi Modulum (DEVICE), Perimed PeriFlux 5000 (DEVICE), Apple Watch Oxygen Sensor (DEVICE), Innovo iP 900AP (DEVICE).
Who is sponsoring clinical trial NCT05784103?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.